These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 15081312

  • 1. Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy.
    Jayasankar V, Pirolli TJ, Bish LT, Berry MF, Burdick J, Grand T, Woo YJ.
    J Mol Cell Cardiol; 2004 Apr; 36(4):531-8. PubMed ID: 15081312
    [Abstract] [Full Text] [Related]

  • 2. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
    Jayasankar V, Bish LT, Pirolli TJ, Berry MF, Burdick J, Woo YJ.
    Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
    [Abstract] [Full Text] [Related]

  • 3. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure.
    Jayasankar V, Woo YJ, Pirolli TJ, Bish LT, Berry MF, Burdick J, Gardner TJ, Sweeney HL.
    J Card Surg; 2005 Jun; 20(1):93-101. PubMed ID: 15673421
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
    Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Berry MF, Burdick J, Bhalla RC, Sharma RV, Gardner TJ, Sweeney HL.
    Circulation; 2004 Sep 14; 110(11 Suppl 1):II180-6. PubMed ID: 15364860
    [Abstract] [Full Text] [Related]

  • 5. Myocardial regeneration therapy for ischemic cardiomyopathy with cyclin A2.
    Woo YJ, Panlilio CM, Cheng RK, Liao GP, Suarez EE, Atluri P, Chaudhry HW.
    J Thorac Cardiovasc Surg; 2007 Apr 14; 133(4):927-33. PubMed ID: 17382628
    [Abstract] [Full Text] [Related]

  • 6. Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure.
    Berry MF, Pirolli TJ, Jayasankar V, Morine KJ, Moise MA, Fisher O, Gardner TJ, Patterson PH, Woo YJ.
    J Thorac Cardiovasc Surg; 2004 Dec 14; 128(6):866-75. PubMed ID: 15573071
    [Abstract] [Full Text] [Related]

  • 7. Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction.
    Ding L, Dong L, Chen X, Zhang L, Xu X, Ferro A, Xu B.
    Circulation; 2009 Sep 01; 120(9):764-73. PubMed ID: 19687354
    [Abstract] [Full Text] [Related]

  • 8. Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure.
    Jayasankar V, Woo YJ, Bish LT, Pirolli TJ, Chatterjee S, Berry MF, Burdick J, Gardner TJ, Sweeney HL.
    Circulation; 2003 Sep 09; 108 Suppl 1():II230-6. PubMed ID: 12970238
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction.
    Smith RS, Agata J, Xia CF, Chao L, Chao J.
    Life Sci; 2005 Apr 08; 76(21):2457-71. PubMed ID: 15763077
    [Abstract] [Full Text] [Related]

  • 11. Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction.
    Hu CH, Wu GF, Wang XQ, Yang YH, Du ZM, He XH, Xiang P.
    Chin Med J (Engl); 2006 Sep 20; 119(18):1499-506. PubMed ID: 16996002
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis.
    Chen LL, Yin H, Huang J.
    Cardiovasc Pathol; 2007 Sep 20; 16(4):221-30. PubMed ID: 17637430
    [Abstract] [Full Text] [Related]

  • 13. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
    Berry MF, Woo YJ, Pirolli TJ, Bish LT, Moise MA, Burdick JW, Morine KJ, Jayasankar V, Gardner TJ, Sweeney HL.
    J Heart Lung Transplant; 2004 Sep 20; 23(9):1061-8. PubMed ID: 15454172
    [Abstract] [Full Text] [Related]

  • 14. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK, Danzi S, Paul JT, Leya G, Klein I, Samarel AM.
    Circ Heart Fail; 2009 May 20; 2(3):243-52. PubMed ID: 19808346
    [Abstract] [Full Text] [Related]

  • 15. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice.
    Li Y, Takemura G, Kosai K, Yuge K, Nagano S, Esaki M, Goto K, Takahashi T, Hayakawa K, Koda M, Kawase Y, Maruyama R, Okada H, Minatoguchi S, Mizuguchi H, Fujiwara T, Fujiwara H.
    Circulation; 2003 May 20; 107(19):2499-506. PubMed ID: 12695295
    [Abstract] [Full Text] [Related]

  • 16. Adaptive or maladaptive response to adenoviral adrenomedullin gene transfer is context-dependent in the heart.
    Leskinen H, Rauma-Pinola T, Szokodi I, Kerkelä R, Pikkarainen S, Uusimaa P, Hautala T, Vuolteenaho O, Ruskoaho H.
    J Gene Med; 2008 Aug 20; 10(8):867-77. PubMed ID: 18615773
    [Abstract] [Full Text] [Related]

  • 17. Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction.
    Kusano K, Tsutsumi Y, Dean J, Gavin M, Ma H, Silver M, Thorne T, Zhu Y, Losordo DW, Aikawa R.
    J Mol Cell Cardiol; 2007 Feb 20; 42(2):390-9. PubMed ID: 17174322
    [Abstract] [Full Text] [Related]

  • 18. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A, Horiba M, Ishiguro H, Takenaka H, Ueda N, Ooboshi H, Opthof T, Kadomatsu K, Kodama I.
    Cardiovasc Res; 2010 Apr 01; 86(1):113-21. PubMed ID: 19969622
    [Abstract] [Full Text] [Related]

  • 19. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL.
    J Thorac Cardiovasc Surg; 2005 Aug 01; 130(2):321-9. PubMed ID: 16077394
    [Abstract] [Full Text] [Related]

  • 20. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state.
    Schalch P, Rahman GF, Patejunas G, Goldschmidt RA, Carbray J, Retuerto MA, Kim D, Esser K, Crystal RG, Rosengart TK.
    J Thorac Cardiovasc Surg; 2004 Feb 01; 127(2):535-40. PubMed ID: 14762365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.